Document Detail


Long-term antiviral treatment for recurrent hepatitis C after liver transplantation.
MedLine Citation:
PMID:  22819767     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND AND AIMS: The management of patients treated for hepatitis C recurrence after liver transplantation and not achieving virological response following treatment with interferon plus ribavirin is controversial. METHODS: A retrospective analysis of the outcomes of 70 patients non-responders to antiviral treatment after liver transplantation was performed. Twenty-one patients (30.0%; Group A) were treated for ≤12 months and 49 (70.0%; Group B) for more than 12 months. RESULTS: The 2 groups were comparable for main demographic, clinical and pathological variables. Median duration of antiviral treatment was 8.2 months in Group A and 33.4 months in Group B. No patient achieved a complete virological response. The 5-year patient hepatitis C-related survival rate was 49.2% in Group A and 88.3% in Group B (P=0.002), while the 5-year graft survival rate was 49.2% in Group A and 85.9% in Group B (P=0.007). The median yearly fibrosis progression rate was 1.21 per year in Group A and 0.40 per year in Group B (P=0.001). CONCLUSIONS: Prolonged antiviral treatment showed an overall beneficial effect in transplanted patients with a recurrent hepatitis C infection and not responding to conventional therapy. The treatment should be continued as long as it is permitted, in order to improve clinical and histological outcomes.
Authors:
Valentina Rosa Bertuzzo; Matteo Cescon; Maria Cristina Morelli; Paolo Di Gioia; Mariarosa Tamè; Stefania Lorenzini; Pietro Andreone; Giorgio Ercolani; Massimo Del Gaudio; Matteo Ravaioli; Alessandro Cucchetti; Alessandro Dazzi; Antonietta D'Errico-Grigioni; Antonio Daniele Pinna
Related Documents :
1982837 - Changes of peritoneal membrane function during long-term capd.
18648207 - Repeated paracentesis in a fetus with meconium peritonitis with massive ascites: a case...
1297737 - Prevention of aortic calcification in patients on hemodialysis by long-term administrat...
6348737 - Is continuous ambulatory peritoneal dialysis the best dialysis choice for insulin depen...
17604187 - International cartilage repair society (icrs) and oswestry macroscopic cartilage evalua...
2693077 - Is the forrest classification a useful tool for planning endoscopic therapy of bleeding...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-20
Journal Detail:
Title:  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver     Volume:  -     ISSN:  1878-3562     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100958385     Medline TA:  Dig Liver Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Department of General Surgery and Organ Transplantation, University of Bologna, Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  SAR studies around a series of triazolopyridines as potent and selective PI3K? inhibitors.
Next Document:  Human ocular biometry.